Il CdA AIFA approva la riclassificazione delle glifozine nella fascia A dei prodotti rimborsati acquistabili in farmacia
30/06/2025
Leggi
Breaking news
Emotional distress as a therapeutic target against persistent poor glycaemic control in subjects with type 1 diabetes: a systematic review
Franc S, Charpentier G
Diabetes Obes Metab. Pub. online 25 Jun 2025.
Leggi
Diagnosis and treatment of type 2 diabetes in adults: a review
Kalyani RR, Neumiller JJ, Maruthur NM, Wexler DJ
JAMA. Pub. online 23 Jun 2025.
Leggi
Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment
DeFronzo RA, Fonseca V, Aroda VR, et al.
Diabetes Care. Pub. online 23 Jun 2025.
Leggi
EMA: First treatment against liver scarring caused by a type of ‘fatty liver disease’. Rezdiffra is indicated for patients with moderate to advanced scarring due to accumulation of fat
20 giugno 2025
Leggi
Weekly fixed-dose insulin efsitora in type 2 diabetes without previous insulin therapy
Rosenstock J, Bailey TS, Connery L, et al.
N Engl J Med. Pub. online 22 Jun 2025.
Leggi
Stem cell–derived, fully differentiated islets for type 1 diabetes
Reichman TW, Markmann JF, Odorico J, et al.
N Engl J Med. Pub. online 20 Jun 2025.
Leggi
2025 concise clinical guidance: an ACC expert consensus statement on medical weight management for optimization of cardiovascular health: a report of the American College of Cardiology Solution Set Oversight Committee
Gilbert O, Gulati M, Gluckman TJ, et al.
J Am Coll Cardiol. Pub. online 16 Jun 2025.
Leggi
Association of maternal overweight and gestational diabetes mellitus with offspring adiposity trajectory: from birth to early adolescence
Deng Y, Tam CHT, Yang A, et al.
Diabetologia. Pub. online 17 Jun 2025.
Leggi
Comparison of semaglutide or dulaglutide versus empagliflozin for risk for death and cardiovascular outcomes among patients with type 2 diabetes : two target trial emulation studies
Saeed A, Mulukutla SR, Thoma F, et al.
Ann Intern Med. Pub. online 17 Jun 2025.
Leggi